GLP-1 DRUG HYPE ON SOCIAL MEDIA FUELS YOUTH HEALTH CONCERNS

GLP-1 medications like Ozempic and Wegovy have become ubiquitous on TikTok, Instagram, and other social apps, where influencers and users share weight-loss results and tips for obtaining the drugs. The flood of content creates potential liability for platforms, as advocates warn the messaging may normalize drug use among minors and distort adolescent views on body image and health. Healthcare experts note that GLP-1s carry serious side effects and are prescribed for specific medical conditions, not general weight loss. Yet social media discussions often omit these details, presenting the drugs as lifestyle solutions. Lawyers tracking social media harm litigation suggest GLP-1 marketing could become the next major claim category against tech companies, similar to body image and eating disorder suits already filed. Regulators and platforms face pressure to monitor health-related content more closely as the drugs' popularity surges among younger demographics.